Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2015 | 10-2014 | 10-2013 | 10-2012 | 10-2011 | |
| Sales | 9,255 | 3,667 | 389 | 940 | 1,003 |
| Cost of Goods | N/A | N/A | N/A | N/A | 34 |
| Gross Profit | 9,255 | 3,667 | 389 | 940 | 969 |
| Operating Expenses | 10,200 | 8,711 | 8,307 | 5,075 | 6,032 |
| Operating Income | -945 | -5,044 | -7,918 | -4,135 | -5,028 |
| Interest Expense | 452 | 1,264 | 1,110 | 8 | 0 |
| Other Income | 18 | -3,299 | -1,053 | -111 | -1,750 |
| Pre-tax Income | -1,379 | -9,606 | -10,080 | -4,253 | -6,778 |
| Income Tax | N/A | N/A | N/A | N/A | 600 |
| Net Income Continuous | -1,379 | -9,606 | -10,080 | -4,253 | -7,378 |
| Net Income | $-1,379 | $-9,606 | $-10,080 | $-4,253 | $-7,378 |
| EPS Basic Total Ops | -0.16 | -1.10 | -1.25 | -0.50 | -1.00 |
| EPS Basic Continuous Ops | -0.16 | -1.10 | -1.28 | -0.59 | -1.11 |
| EPS Diluted Total Ops | -0.16 | -1.10 | -1.25 | -0.50 | -1.00 |
| EPS Diluted Continuous Ops | -0.16 | -1.10 | -1.28 | -0.59 | -1.11 |
| EBITDA(a) | $-155 | $-3,710 | $-6,927 | $-4,135 | $-5,020 |